nodes	percent_of_prediction	percent_of_DWPC	metapath
Vismodegib—ALB—atherosclerosis	0.194	1	CbGaD
Vismodegib—ABCG2—Rosuvastatin—atherosclerosis	0.0585	0.0989	CbGbCtD
Vismodegib—ABCG2—Ezetimibe—atherosclerosis	0.0585	0.0989	CbGbCtD
Vismodegib—ABCG2—Pravastatin—atherosclerosis	0.0532	0.09	CbGbCtD
Vismodegib—ALB—Rosuvastatin—atherosclerosis	0.0403	0.0682	CbGbCtD
Vismodegib—CYP2C8—Simvastatin—atherosclerosis	0.029	0.049	CbGbCtD
Vismodegib—CYP2C8—Pravastatin—atherosclerosis	0.0283	0.048	CbGbCtD
Vismodegib—CYP2C8—Lovastatin—atherosclerosis	0.0283	0.048	CbGbCtD
Vismodegib—CYP2C19—Rosuvastatin—atherosclerosis	0.0261	0.0442	CbGbCtD
Vismodegib—CYP2C19—Simvastatin—atherosclerosis	0.0243	0.0411	CbGbCtD
Vismodegib—CYP2C19—Lovastatin—atherosclerosis	0.0238	0.0402	CbGbCtD
Vismodegib—CYP2C9—Rosuvastatin—atherosclerosis	0.0217	0.0368	CbGbCtD
Vismodegib—ABCB1—Ezetimibe—atherosclerosis	0.0211	0.0357	CbGbCtD
Vismodegib—CYP2C9—Simvastatin—atherosclerosis	0.0202	0.0342	CbGbCtD
Vismodegib—CYP2C9—Lovastatin—atherosclerosis	0.0198	0.0334	CbGbCtD
Vismodegib—CYP2C9—Pravastatin—atherosclerosis	0.0198	0.0334	CbGbCtD
Vismodegib—ABCB1—Simvastatin—atherosclerosis	0.0196	0.0332	CbGbCtD
Vismodegib—ABCB1—Lovastatin—atherosclerosis	0.0192	0.0325	CbGbCtD
Vismodegib—ABCB1—Pravastatin—atherosclerosis	0.0192	0.0325	CbGbCtD
Vismodegib—CYP3A4—Rosuvastatin—atherosclerosis	0.0126	0.0214	CbGbCtD
Vismodegib—CYP3A4—Ezetimibe—atherosclerosis	0.0126	0.0214	CbGbCtD
Vismodegib—CYP3A4—Simvastatin—atherosclerosis	0.0117	0.0199	CbGbCtD
Vismodegib—CYP3A4—Lovastatin—atherosclerosis	0.0115	0.0194	CbGbCtD
Vismodegib—CYP3A4—Pravastatin—atherosclerosis	0.0115	0.0194	CbGbCtD
Vismodegib—SHH—appendage—atherosclerosis	0.00747	0.464	CbGeAlD
Vismodegib—Musculoskeletal disorder—Rosuvastatin—atherosclerosis	0.00551	0.0572	CcSEcCtD
Vismodegib—Musculoskeletal disorder—Simvastatin—atherosclerosis	0.00437	0.0453	CcSEcCtD
Vismodegib—SHH—connective tissue—atherosclerosis	0.00213	0.132	CbGeAlD
Vismodegib—Hepatic enzyme increased—Rosuvastatin—atherosclerosis	0.00208	0.0216	CcSEcCtD
Vismodegib—Neoplasm malignant—Ezetimibe—atherosclerosis	0.00192	0.0199	CcSEcCtD
Vismodegib—Sulfasalazine—PLA2G1B—atherosclerosis	0.00184	0.345	CrCbGaD
Vismodegib—Musculoskeletal pain—Lovastatin—atherosclerosis	0.00169	0.0175	CcSEcCtD
Vismodegib—Phosphatase alkaline increased—Lovastatin—atherosclerosis	0.00167	0.0173	CcSEcCtD
Vismodegib—Phosphatase alkaline increased—Ezetimibe—atherosclerosis	0.00164	0.017	CcSEcCtD
Vismodegib—Phosphatase alkaline increased—Simvastatin—atherosclerosis	0.00156	0.0162	CcSEcCtD
Vismodegib—SMO—connective tissue—atherosclerosis	0.00149	0.0925	CbGeAlD
Vismodegib—Musculoskeletal pain—Pravastatin—atherosclerosis	0.00143	0.0148	CcSEcCtD
Vismodegib—Phosphatase alkaline increased—Pravastatin—atherosclerosis	0.00141	0.0146	CcSEcCtD
Vismodegib—Blood alkaline phosphatase increased—Lovastatin—atherosclerosis	0.00139	0.0144	CcSEcCtD
Vismodegib—Blood alkaline phosphatase increased—Ezetimibe—atherosclerosis	0.00137	0.0142	CcSEcCtD
Vismodegib—Sorafenib—CSF1R—atherosclerosis	0.00131	0.247	CrCbGaD
Vismodegib—Blood alkaline phosphatase increased—Simvastatin—atherosclerosis	0.0013	0.0135	CcSEcCtD
Vismodegib—Breast disorder—Rosuvastatin—atherosclerosis	0.00129	0.0134	CcSEcCtD
Vismodegib—Pain in extremity—Lovastatin—atherosclerosis	0.00121	0.0126	CcSEcCtD
Vismodegib—Pain in extremity—Ezetimibe—atherosclerosis	0.00119	0.0123	CcSEcCtD
Vismodegib—Blood alkaline phosphatase increased—Pravastatin—atherosclerosis	0.00118	0.0122	CcSEcCtD
Vismodegib—SMO—adipose tissue—atherosclerosis	0.00114	0.071	CbGeAlD
Vismodegib—Breast disorder—Ezetimibe—atherosclerosis	0.00107	0.0111	CcSEcCtD
Vismodegib—Aspartate aminotransferase increased—Ezetimibe—atherosclerosis	0.00107	0.0111	CcSEcCtD
Vismodegib—Sulfasalazine—ALOX5—atherosclerosis	0.000975	0.183	CrCbGaD
Vismodegib—Connective tissue disorder—Ezetimibe—atherosclerosis	0.000808	0.00837	CcSEcCtD
Vismodegib—SMO—liver—atherosclerosis	0.000802	0.0498	CbGeAlD
Vismodegib—Weight decreased—Pravastatin—atherosclerosis	0.000801	0.00831	CcSEcCtD
Vismodegib—Alopecia—Lovastatin—atherosclerosis	0.000741	0.00768	CcSEcCtD
Vismodegib—Myalgia—Rosuvastatin—atherosclerosis	0.000733	0.0076	CcSEcCtD
Vismodegib—Arthralgia—Rosuvastatin—atherosclerosis	0.000733	0.0076	CcSEcCtD
Vismodegib—Alopecia—Ezetimibe—atherosclerosis	0.000726	0.00753	CcSEcCtD
Vismodegib—Malnutrition—Ezetimibe—atherosclerosis	0.000716	0.00742	CcSEcCtD
Vismodegib—Dysgeusia—Lovastatin—atherosclerosis	0.000714	0.00741	CcSEcCtD
Vismodegib—Back pain—Lovastatin—atherosclerosis	0.000706	0.00732	CcSEcCtD
Vismodegib—Muscle spasms—Lovastatin—atherosclerosis	0.000701	0.00727	CcSEcCtD
Vismodegib—Alopecia—Simvastatin—atherosclerosis	0.000693	0.00718	CcSEcCtD
Vismodegib—Back pain—Ezetimibe—atherosclerosis	0.000692	0.00718	CcSEcCtD
Vismodegib—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000689	0.00714	CcSEcCtD
Vismodegib—Muscle spasms—Ezetimibe—atherosclerosis	0.000688	0.00713	CcSEcCtD
Vismodegib—Dysgeusia—Simvastatin—atherosclerosis	0.000668	0.00693	CcSEcCtD
Vismodegib—Muscle spasms—Simvastatin—atherosclerosis	0.000656	0.0068	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00064	0.00664	CcSEcCtD
Vismodegib—Alopecia—Niacin—atherosclerosis	0.000636	0.00659	CcSEcCtD
Vismodegib—Malnutrition—Niacin—atherosclerosis	0.000627	0.0065	CcSEcCtD
Vismodegib—Alopecia—Pravastatin—atherosclerosis	0.000626	0.00649	CcSEcCtD
Vismodegib—Myalgia—Lovastatin—atherosclerosis	0.000621	0.00644	CcSEcCtD
Vismodegib—Arthralgia—Lovastatin—atherosclerosis	0.000621	0.00644	CcSEcCtD
Vismodegib—Dyspepsia—Rosuvastatin—atherosclerosis	0.000618	0.00641	CcSEcCtD
Vismodegib—Myalgia—Ezetimibe—atherosclerosis	0.000609	0.00632	CcSEcCtD
Vismodegib—Arthralgia—Ezetimibe—atherosclerosis	0.000609	0.00632	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000605	0.00627	CcSEcCtD
Vismodegib—Dysgeusia—Pravastatin—atherosclerosis	0.000604	0.00626	CcSEcCtD
Vismodegib—Muscle spasms—Niacin—atherosclerosis	0.000602	0.00625	CcSEcCtD
Vismodegib—Pain—Rosuvastatin—atherosclerosis	0.000601	0.00623	CcSEcCtD
Vismodegib—Constipation—Rosuvastatin—atherosclerosis	0.000601	0.00623	CcSEcCtD
Vismodegib—Muscle spasms—Pravastatin—atherosclerosis	0.000593	0.00615	CcSEcCtD
Vismodegib—Arthralgia—Simvastatin—atherosclerosis	0.000581	0.00602	CcSEcCtD
Vismodegib—Myalgia—Simvastatin—atherosclerosis	0.000581	0.00602	CcSEcCtD
Vismodegib—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000575	0.00596	CcSEcCtD
Vismodegib—Nervous system disorder—Ezetimibe—atherosclerosis	0.000573	0.00594	CcSEcCtD
Vismodegib—Skin disorder—Ezetimibe—atherosclerosis	0.000567	0.00588	CcSEcCtD
Vismodegib—Sulfasalazine—PPARG—atherosclerosis	0.000558	0.105	CrCbGaD
Vismodegib—Abdominal pain—Rosuvastatin—atherosclerosis	0.000555	0.00576	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000542	0.00562	CcSEcCtD
Vismodegib—Arthralgia—Niacin—atherosclerosis	0.000533	0.00553	CcSEcCtD
Vismodegib—Myalgia—Niacin—atherosclerosis	0.000533	0.00553	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000532	0.00552	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00053	0.00549	CcSEcCtD
Vismodegib—Arthralgia—Pravastatin—atherosclerosis	0.000525	0.00545	CcSEcCtD
Vismodegib—Myalgia—Pravastatin—atherosclerosis	0.000525	0.00545	CcSEcCtD
Vismodegib—Dyspepsia—Lovastatin—atherosclerosis	0.000524	0.00543	CcSEcCtD
Vismodegib—Decreased appetite—Lovastatin—atherosclerosis	0.000518	0.00537	CcSEcCtD
Vismodegib—Dyspepsia—Ezetimibe—atherosclerosis	0.000514	0.00533	CcSEcCtD
Vismodegib—Fatigue—Lovastatin—atherosclerosis	0.000513	0.00532	CcSEcCtD
Vismodegib—Constipation—Lovastatin—atherosclerosis	0.000509	0.00528	CcSEcCtD
Vismodegib—Pain—Lovastatin—atherosclerosis	0.000509	0.00528	CcSEcCtD
Vismodegib—Decreased appetite—Ezetimibe—atherosclerosis	0.000508	0.00526	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000507	0.00526	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000504	0.00523	CcSEcCtD
Vismodegib—Asthenia—Rosuvastatin—atherosclerosis	0.000504	0.00523	CcSEcCtD
Vismodegib—Fatigue—Ezetimibe—atherosclerosis	0.000504	0.00522	CcSEcCtD
Vismodegib—Pain—Ezetimibe—atherosclerosis	0.000499	0.00518	CcSEcCtD
Vismodegib—Constipation—Ezetimibe—atherosclerosis	0.000499	0.00518	CcSEcCtD
Vismodegib—Pruritus—Rosuvastatin—atherosclerosis	0.000497	0.00515	CcSEcCtD
Vismodegib—Skin disorder—Niacin—atherosclerosis	0.000497	0.00515	CcSEcCtD
Vismodegib—Dyspepsia—Simvastatin—atherosclerosis	0.00049	0.00508	CcSEcCtD
Vismodegib—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000487	0.00505	CcSEcCtD
Vismodegib—Decreased appetite—Simvastatin—atherosclerosis	0.000484	0.00502	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000481	0.00499	CcSEcCtD
Vismodegib—Diarrhoea—Rosuvastatin—atherosclerosis	0.000481	0.00498	CcSEcCtD
Vismodegib—Fatigue—Simvastatin—atherosclerosis	0.00048	0.00498	CcSEcCtD
Vismodegib—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000478	0.00495	CcSEcCtD
Vismodegib—Pain—Simvastatin—atherosclerosis	0.000476	0.00494	CcSEcCtD
Vismodegib—Constipation—Simvastatin—atherosclerosis	0.000476	0.00494	CcSEcCtD
Vismodegib—Abdominal pain—Lovastatin—atherosclerosis	0.000471	0.00488	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000466	0.00483	CcSEcCtD
Vismodegib—Abdominal pain—Ezetimibe—atherosclerosis	0.000462	0.00479	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000459	0.00476	CcSEcCtD
Vismodegib—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000455	0.00472	CcSEcCtD
Vismodegib—Dyspepsia—Niacin—atherosclerosis	0.00045	0.00467	CcSEcCtD
Vismodegib—Decreased appetite—Niacin—atherosclerosis	0.000445	0.00461	CcSEcCtD
Vismodegib—Dyspepsia—Pravastatin—atherosclerosis	0.000443	0.0046	CcSEcCtD
Vismodegib—Rash—Rosuvastatin—atherosclerosis	0.000443	0.00459	CcSEcCtD
Vismodegib—Dermatitis—Rosuvastatin—atherosclerosis	0.000443	0.00459	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Niacin—atherosclerosis	0.000442	0.00458	CcSEcCtD
Vismodegib—Abdominal pain—Simvastatin—atherosclerosis	0.00044	0.00456	CcSEcCtD
Vismodegib—Decreased appetite—Pravastatin—atherosclerosis	0.000438	0.00454	CcSEcCtD
Vismodegib—Pain—Niacin—atherosclerosis	0.000437	0.00453	CcSEcCtD
Vismodegib—Fatigue—Pravastatin—atherosclerosis	0.000434	0.0045	CcSEcCtD
Vismodegib—Constipation—Pravastatin—atherosclerosis	0.000431	0.00446	CcSEcCtD
Vismodegib—Pain—Pravastatin—atherosclerosis	0.000431	0.00446	CcSEcCtD
Vismodegib—Asthenia—Lovastatin—atherosclerosis	0.000427	0.00443	CcSEcCtD
Vismodegib—Pruritus—Lovastatin—atherosclerosis	0.000421	0.00437	CcSEcCtD
Vismodegib—Asthenia—Ezetimibe—atherosclerosis	0.000419	0.00434	CcSEcCtD
Vismodegib—Gastrointestinal pain—Niacin—atherosclerosis	0.000418	0.00434	CcSEcCtD
Vismodegib—Nausea—Rosuvastatin—atherosclerosis	0.000417	0.00433	CcSEcCtD
Vismodegib—Pruritus—Ezetimibe—atherosclerosis	0.000413	0.00428	CcSEcCtD
Vismodegib—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000412	0.00427	CcSEcCtD
Vismodegib—Diarrhoea—Lovastatin—atherosclerosis	0.000407	0.00422	CcSEcCtD
Vismodegib—Abdominal pain—Niacin—atherosclerosis	0.000404	0.00419	CcSEcCtD
Vismodegib—Etoricoxib—PTGS2—atherosclerosis	0.0004	0.0751	CrCbGaD
Vismodegib—Asthenia—Simvastatin—atherosclerosis	0.0004	0.00414	CcSEcCtD
Vismodegib—Diarrhoea—Ezetimibe—atherosclerosis	0.0004	0.00414	CcSEcCtD
Vismodegib—Abdominal pain—Pravastatin—atherosclerosis	0.000398	0.00413	CcSEcCtD
Vismodegib—Pruritus—Simvastatin—atherosclerosis	0.000394	0.00409	CcSEcCtD
Vismodegib—Diarrhoea—Simvastatin—atherosclerosis	0.000381	0.00395	CcSEcCtD
Vismodegib—Vomiting—Lovastatin—atherosclerosis	0.000379	0.00393	CcSEcCtD
Vismodegib—Rash—Lovastatin—atherosclerosis	0.000375	0.00389	CcSEcCtD
Vismodegib—ABCB1—blood vessel—atherosclerosis	0.000375	0.0233	CbGeAlD
Vismodegib—Dermatitis—Lovastatin—atherosclerosis	0.000375	0.00389	CcSEcCtD
Vismodegib—Vomiting—Ezetimibe—atherosclerosis	0.000371	0.00385	CcSEcCtD
Vismodegib—Rash—Ezetimibe—atherosclerosis	0.000368	0.00382	CcSEcCtD
Vismodegib—Dermatitis—Ezetimibe—atherosclerosis	0.000368	0.00381	CcSEcCtD
Vismodegib—Asthenia—Niacin—atherosclerosis	0.000367	0.0038	CcSEcCtD
Vismodegib—Pruritus—Niacin—atherosclerosis	0.000362	0.00375	CcSEcCtD
Vismodegib—Asthenia—Pravastatin—atherosclerosis	0.000361	0.00375	CcSEcCtD
Vismodegib—Pruritus—Pravastatin—atherosclerosis	0.000356	0.00369	CcSEcCtD
Vismodegib—Vomiting—Simvastatin—atherosclerosis	0.000354	0.00367	CcSEcCtD
Vismodegib—Nausea—Lovastatin—atherosclerosis	0.000354	0.00367	CcSEcCtD
Vismodegib—Rash—Simvastatin—atherosclerosis	0.000351	0.00364	CcSEcCtD
Vismodegib—Dermatitis—Simvastatin—atherosclerosis	0.000351	0.00364	CcSEcCtD
Vismodegib—ORM1—liver—atherosclerosis	0.000351	0.0218	CbGeAlD
Vismodegib—Diarrhoea—Niacin—atherosclerosis	0.00035	0.00363	CcSEcCtD
Vismodegib—Nausea—Ezetimibe—atherosclerosis	0.000347	0.0036	CcSEcCtD
Vismodegib—Diarrhoea—Pravastatin—atherosclerosis	0.000345	0.00357	CcSEcCtD
Vismodegib—Nausea—Simvastatin—atherosclerosis	0.000331	0.00343	CcSEcCtD
Vismodegib—Vomiting—Niacin—atherosclerosis	0.000325	0.00337	CcSEcCtD
Vismodegib—Rash—Niacin—atherosclerosis	0.000322	0.00334	CcSEcCtD
Vismodegib—Dermatitis—Niacin—atherosclerosis	0.000322	0.00334	CcSEcCtD
Vismodegib—Vomiting—Pravastatin—atherosclerosis	0.00032	0.00332	CcSEcCtD
Vismodegib—Rash—Pravastatin—atherosclerosis	0.000317	0.00329	CcSEcCtD
Vismodegib—Dermatitis—Pravastatin—atherosclerosis	0.000317	0.00329	CcSEcCtD
Vismodegib—CYP2C9—cardiovascular system—atherosclerosis	0.00031	0.0193	CbGeAlD
Vismodegib—ALB—liver—atherosclerosis	0.000307	0.0191	CbGeAlD
Vismodegib—Nausea—Niacin—atherosclerosis	0.000304	0.00315	CcSEcCtD
Vismodegib—ABCG2—adipose tissue—atherosclerosis	0.000299	0.0186	CbGeAlD
Vismodegib—Nausea—Pravastatin—atherosclerosis	0.000299	0.0031	CcSEcCtD
Vismodegib—CYP2C19—liver—atherosclerosis	0.000247	0.0154	CbGeAlD
Vismodegib—Sulfasalazine—PTGS2—atherosclerosis	0.000236	0.0443	CrCbGaD
Vismodegib—CYP2C8—liver—atherosclerosis	0.000216	0.0134	CbGeAlD
Vismodegib—ABCG2—liver—atherosclerosis	0.00021	0.013	CbGeAlD
Vismodegib—CYP2C9—liver—atherosclerosis	0.000192	0.0119	CbGeAlD
Vismodegib—ABCB1—cardiovascular system—atherosclerosis	0.000167	0.0104	CbGeAlD
Vismodegib—ABCB1—adipose tissue—atherosclerosis	0.000148	0.00917	CbGeAlD
Vismodegib—CYP3A4—liver—atherosclerosis	0.000146	0.00908	CbGeAlD
Vismodegib—ABCB1—liver—atherosclerosis	0.000104	0.00643	CbGeAlD
Vismodegib—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	1.18e-05	0.000122	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	1.18e-05	0.000122	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.18e-05	0.000122	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—BGN—atherosclerosis	1.17e-05	0.00012	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ABCG5—atherosclerosis	1.16e-05	0.00012	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.16e-05	0.00012	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—APOA5—atherosclerosis	1.15e-05	0.000119	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.15e-05	0.000119	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PLA2G1B—atherosclerosis	1.14e-05	0.000118	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.14e-05	0.000117	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—IGF1—atherosclerosis	1.14e-05	0.000117	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.13e-05	0.000117	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—APOB—atherosclerosis	1.13e-05	0.000117	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.12e-05	0.000116	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—IL6—atherosclerosis	1.12e-05	0.000116	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—LPA—atherosclerosis	1.12e-05	0.000116	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.11e-05	0.000115	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.11e-05	0.000115	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PLA2G1B—atherosclerosis	1.11e-05	0.000115	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—NAMPT—atherosclerosis	1.1e-05	0.000114	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.1e-05	0.000114	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—GSTM1—atherosclerosis	1.1e-05	0.000114	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ALOX5—atherosclerosis	1.1e-05	0.000114	CbGpPWpGaD
Vismodegib—ALB—Metabolism—NAMPT—atherosclerosis	1.1e-05	0.000113	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.1e-05	0.000113	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—LIPC—atherosclerosis	1.1e-05	0.000113	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—AKT1—atherosclerosis	1.09e-05	0.000113	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.09e-05	0.000113	CbGpPWpGaD
Vismodegib—ALB—Metabolism—LIPC—atherosclerosis	1.09e-05	0.000113	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—APOC3—atherosclerosis	1.09e-05	0.000113	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—BGN—atherosclerosis	1.09e-05	0.000112	CbGpPWpGaD
Vismodegib—ALB—Metabolism—APOC3—atherosclerosis	1.08e-05	0.000112	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—LDLR—atherosclerosis	1.08e-05	0.000112	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.08e-05	0.000112	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—SERPINE1—atherosclerosis	1.08e-05	0.000112	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—LPL—atherosclerosis	1.08e-05	0.000111	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—APOA5—atherosclerosis	1.08e-05	0.000111	CbGpPWpGaD
Vismodegib—ALB—Metabolism—LDLR—atherosclerosis	1.08e-05	0.000111	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—ALOX5—atherosclerosis	1.07e-05	0.000111	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CETP—atherosclerosis	1.06e-05	0.000109	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—GPX1—atherosclerosis	1.05e-05	0.000109	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CETP—atherosclerosis	1.05e-05	0.000109	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.05e-05	0.000108	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	1.04e-05	0.000107	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—AKT1—atherosclerosis	1.04e-05	0.000107	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.03e-05	0.000107	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—NOS3—atherosclerosis	1.03e-05	0.000107	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.03e-05	0.000106	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—CD36—atherosclerosis	1.02e-05	0.000106	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.02e-05	0.000105	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.01e-05	0.000105	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.01e-05	0.000105	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—SCARB1—atherosclerosis	1.01e-05	0.000105	CbGpPWpGaD
Vismodegib—ALB—Metabolism—SCARB1—atherosclerosis	1.01e-05	0.000104	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ALOX5—atherosclerosis	1e-05	0.000104	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	9.87e-06	0.000102	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—NAMPT—atherosclerosis	9.85e-06	0.000102	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	9.8e-06	0.000101	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—LIPC—atherosclerosis	9.79e-06	0.000101	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ABCG1—atherosclerosis	9.78e-06	0.000101	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—APOC3—atherosclerosis	9.73e-06	0.000101	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—MTHFR—atherosclerosis	9.71e-06	0.0001	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—LDLR—atherosclerosis	9.67e-06	9.99e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—NAMPT—atherosclerosis	9.62e-06	9.94e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—HMGCR—atherosclerosis	9.57e-06	9.89e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—LIPC—atherosclerosis	9.56e-06	9.88e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PPARA—atherosclerosis	9.53e-06	9.85e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—HMGCR—atherosclerosis	9.52e-06	9.83e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—APOC3—atherosclerosis	9.5e-06	9.81e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CETP—atherosclerosis	9.45e-06	9.76e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—LDLR—atherosclerosis	9.44e-06	9.75e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	9.25e-06	9.56e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—AGT—atherosclerosis	9.23e-06	9.54e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CETP—atherosclerosis	9.22e-06	9.53e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—FABP4—atherosclerosis	9.19e-06	9.5e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—LCAT—atherosclerosis	9.19e-06	9.5e-05	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	9.19e-06	9.5e-05	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	9.05e-06	9.35e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—SCARB1—atherosclerosis	9.05e-06	9.35e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—APOE—atherosclerosis	9.04e-06	9.34e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—APOA4—atherosclerosis	9.03e-06	9.33e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—NAMPT—atherosclerosis	8.98e-06	9.28e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—CAV1—atherosclerosis	8.96e-06	9.26e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—APOA1—atherosclerosis	8.94e-06	9.24e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	8.93e-06	9.23e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—LIPC—atherosclerosis	8.93e-06	9.23e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—APOC3—atherosclerosis	8.87e-06	9.17e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CYP7A1—atherosclerosis	8.87e-06	9.16e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—SCARB1—atherosclerosis	8.83e-06	9.12e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—LDLR—atherosclerosis	8.82e-06	9.11e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	8.81e-06	9.1e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	8.63e-06	8.92e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CETP—atherosclerosis	8.61e-06	8.9e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	8.58e-06	8.87e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—HMGCR—atherosclerosis	8.54e-06	8.83e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—ABCA1—atherosclerosis	8.53e-06	8.82e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—ABCA1—atherosclerosis	8.48e-06	8.77e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—HMGCR—atherosclerosis	8.34e-06	8.62e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—SCARB1—atherosclerosis	8.25e-06	8.52e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CYP27A1—atherosclerosis	8.2e-06	8.47e-05	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	8.17e-06	8.45e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PIK3CG—atherosclerosis	8.16e-06	8.43e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	8.03e-06	8.3e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PPARG—atherosclerosis	7.88e-06	8.14e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—HMGCR—atherosclerosis	7.79e-06	8.05e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	7.77e-06	8.03e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—APOA2—atherosclerosis	7.77e-06	8.03e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ALOX15—atherosclerosis	7.77e-06	8.03e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	7.77e-06	8.03e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—INS—atherosclerosis	7.72e-06	7.98e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	7.71e-06	7.96e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ABCG5—atherosclerosis	7.67e-06	7.93e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ABCA1—atherosclerosis	7.61e-06	7.87e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—ABCA1—atherosclerosis	7.43e-06	7.68e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—VEGFA—atherosclerosis	7.43e-06	7.67e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—LPA—atherosclerosis	7.41e-06	7.66e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—HMOX1—atherosclerosis	7.32e-06	7.56e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—HMOX1—atherosclerosis	7.28e-06	7.52e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—BGN—atherosclerosis	7.18e-06	7.42e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—APOA5—atherosclerosis	7.11e-06	7.34e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—ALB—atherosclerosis	7.08e-06	7.32e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	7.03e-06	7.26e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—MAPK3—atherosclerosis	7.03e-06	7.26e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—APOB—atherosclerosis	7.01e-06	7.24e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—APOB—atherosclerosis	6.97e-06	7.2e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ABCA1—atherosclerosis	6.94e-06	7.17e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	6.84e-06	7.07e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—GSTM1—atherosclerosis	6.82e-06	7.05e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—TGFB1—atherosclerosis	6.82e-06	7.04e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—GSTM1—atherosclerosis	6.78e-06	7.01e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—NOS3—atherosclerosis	6.77e-06	7e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—LPL—atherosclerosis	6.69e-06	6.92e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—LPL—atherosclerosis	6.66e-06	6.88e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ALOX5—atherosclerosis	6.61e-06	6.83e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—HMOX1—atherosclerosis	6.53e-06	6.75e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—GPX1—atherosclerosis	6.53e-06	6.75e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—GPX1—atherosclerosis	6.49e-06	6.71e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—HMOX1—atherosclerosis	6.38e-06	6.59e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CD36—atherosclerosis	6.36e-06	6.57e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CD36—atherosclerosis	6.32e-06	6.54e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—APOB—atherosclerosis	6.26e-06	6.47e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PTGS2—atherosclerosis	6.2e-06	6.4e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—APOB—atherosclerosis	6.11e-06	6.31e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GSTM1—atherosclerosis	6.09e-06	6.29e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—MTHFR—atherosclerosis	6.03e-06	6.23e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—MTHFR—atherosclerosis	5.99e-06	6.19e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—LPL—atherosclerosis	5.98e-06	6.17e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—HMOX1—atherosclerosis	5.96e-06	6.16e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GSTM1—atherosclerosis	5.94e-06	6.14e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—NAMPT—atherosclerosis	5.93e-06	6.12e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PPARA—atherosclerosis	5.91e-06	6.11e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—LIPC—atherosclerosis	5.89e-06	6.08e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PPARA—atherosclerosis	5.88e-06	6.08e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—APOC3—atherosclerosis	5.85e-06	6.05e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—LPL—atherosclerosis	5.83e-06	6.03e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GPX1—atherosclerosis	5.83e-06	6.02e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—LDLR—atherosclerosis	5.82e-06	6.01e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—AGT—atherosclerosis	5.73e-06	5.92e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—APOB—atherosclerosis	5.71e-06	5.9e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—AGT—atherosclerosis	5.69e-06	5.88e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GPX1—atherosclerosis	5.69e-06	5.88e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CETP—atherosclerosis	5.68e-06	5.87e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CD36—atherosclerosis	5.68e-06	5.87e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—APOE—atherosclerosis	5.61e-06	5.8e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—APOE—atherosclerosis	5.58e-06	5.77e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CAV1—atherosclerosis	5.56e-06	5.74e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GSTM1—atherosclerosis	5.55e-06	5.74e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—APOA1—atherosclerosis	5.55e-06	5.73e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CD36—atherosclerosis	5.54e-06	5.73e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CAV1—atherosclerosis	5.53e-06	5.71e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—APOA1—atherosclerosis	5.52e-06	5.7e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—LPL—atherosclerosis	5.45e-06	5.63e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—SCARB1—atherosclerosis	5.44e-06	5.62e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—MTHFR—atherosclerosis	5.38e-06	5.56e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GPX1—atherosclerosis	5.32e-06	5.49e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PPARA—atherosclerosis	5.28e-06	5.45e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—MTHFR—atherosclerosis	5.25e-06	5.43e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CD36—atherosclerosis	5.18e-06	5.35e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PPARA—atherosclerosis	5.15e-06	5.32e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—HMGCR—atherosclerosis	5.14e-06	5.31e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—AGT—atherosclerosis	5.11e-06	5.28e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PIK3CG—atherosclerosis	5.06e-06	5.23e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PIK3CG—atherosclerosis	5.04e-06	5.2e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—APOE—atherosclerosis	5.01e-06	5.18e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—AGT—atherosclerosis	4.99e-06	5.16e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CAV1—atherosclerosis	4.96e-06	5.13e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—APOA1—atherosclerosis	4.95e-06	5.12e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—MTHFR—atherosclerosis	4.91e-06	5.07e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—APOE—atherosclerosis	4.89e-06	5.05e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PPARG—atherosclerosis	4.89e-06	5.05e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PPARG—atherosclerosis	4.86e-06	5.02e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CAV1—atherosclerosis	4.84e-06	5e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—APOA1—atherosclerosis	4.83e-06	4.99e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PPARA—atherosclerosis	4.81e-06	4.97e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—INS—atherosclerosis	4.79e-06	4.95e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—INS—atherosclerosis	4.77e-06	4.93e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—AKT1—atherosclerosis	4.74e-06	4.9e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—AGT—atherosclerosis	4.66e-06	4.82e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ABCA1—atherosclerosis	4.58e-06	4.73e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—APOE—atherosclerosis	4.57e-06	4.72e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CAV1—atherosclerosis	4.52e-06	4.68e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PIK3CG—atherosclerosis	4.52e-06	4.67e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—APOA1—atherosclerosis	4.51e-06	4.66e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PIK3CG—atherosclerosis	4.41e-06	4.56e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—ALB—atherosclerosis	4.39e-06	4.54e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PPARG—atherosclerosis	4.36e-06	4.51e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—INS—atherosclerosis	4.28e-06	4.42e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PPARG—atherosclerosis	4.26e-06	4.4e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—NOS3—atherosclerosis	4.2e-06	4.34e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—NOS3—atherosclerosis	4.18e-06	4.32e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—INS—atherosclerosis	4.18e-06	4.32e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PIK3CG—atherosclerosis	4.12e-06	4.26e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PPARG—atherosclerosis	3.98e-06	4.11e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—HMOX1—atherosclerosis	3.93e-06	4.06e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ALB—atherosclerosis	3.92e-06	4.05e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—INS—atherosclerosis	3.9e-06	4.03e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PTGS2—atherosclerosis	3.84e-06	3.97e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—ALB—atherosclerosis	3.83e-06	3.96e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PTGS2—atherosclerosis	3.82e-06	3.95e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—APOB—atherosclerosis	3.76e-06	3.89e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—NOS3—atherosclerosis	3.75e-06	3.88e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—NOS3—atherosclerosis	3.66e-06	3.78e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GSTM1—atherosclerosis	3.66e-06	3.78e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—LPL—atherosclerosis	3.59e-06	3.71e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ALB—atherosclerosis	3.58e-06	3.7e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GPX1—atherosclerosis	3.51e-06	3.62e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PTGS2—atherosclerosis	3.43e-06	3.55e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—NOS3—atherosclerosis	3.42e-06	3.54e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CD36—atherosclerosis	3.41e-06	3.53e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PTGS2—atherosclerosis	3.35e-06	3.46e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—MTHFR—atherosclerosis	3.24e-06	3.34e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PPARA—atherosclerosis	3.17e-06	3.28e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PTGS2—atherosclerosis	3.13e-06	3.23e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—AKT1—atherosclerosis	3.11e-06	3.22e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—AGT—atherosclerosis	3.07e-06	3.18e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—APOE—atherosclerosis	3.01e-06	3.11e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CAV1—atherosclerosis	2.98e-06	3.08e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—APOA1—atherosclerosis	2.98e-06	3.08e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PIK3CG—atherosclerosis	2.72e-06	2.81e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PPARG—atherosclerosis	2.62e-06	2.71e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—INS—atherosclerosis	2.57e-06	2.66e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ALB—atherosclerosis	2.36e-06	2.44e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—NOS3—atherosclerosis	2.26e-06	2.33e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PTGS2—atherosclerosis	2.06e-06	2.13e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—AKT1—atherosclerosis	1.93e-06	2e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—AKT1—atherosclerosis	1.92e-06	1.99e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—AKT1—atherosclerosis	1.72e-06	1.78e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—AKT1—atherosclerosis	1.68e-06	1.74e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—AKT1—atherosclerosis	1.57e-06	1.63e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—AKT1—atherosclerosis	1.04e-06	1.07e-05	CbGpPWpGaD
